3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
Hodgkin Disease
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Biphenotypic, Acute
2
Burkitt Lymphoma
2
Teratoma
1
Solid Tumors
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Multi-centric Castleman's Disease
1
Malignant mesenchymal tumor
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphadenopathy
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid
1
Leukemia
1
Hematologic Neoplasms
1
HIV Infections
1
Glioma
1
Glioblastoma
1
Interventions
Specimen Handling
4
Doxorubicin
4
pembrolizumab
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
pazopanib
2
palbociclib
2
Radiotherapy
2
Radiation
2
Ifosfamide
2
talimogene laherparepvec
1
selinexor
1
ribociclib
1
peposertib
1
mirdametinib
1
liposomal doxorubicin
1
cemiplimab
1
abemaciclib
1
X-Rays
1
Surgical Procedures, Operative
1
Proton Therapy
1
Neoadjuvant Therapy
1
Immunoglobulin G
1
Histamine H2 Antagonists
1
Gemcitabine
1
Famotidine
1
Everolimus
1
Docetaxel
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
Filgrastim
×
30 days
×
Clear all
No trials found.